← Leaderboards
Thomas Patterson
University Of Texas Hlth Science Center
$12,951,470
Attributed
$12,951,470
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.4M · FY2010–25$5M$3.8M$2.5M$1.3M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,951,470 · 5
By mechanism
N01$12,738,269 · 5
N02$213,201 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Science Center
Same institution · by research overlap
- Thomas F Patterson$792,472
Others in their field
Top investigators on “Contracts”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,154,975,474
- Leonard Freedman · Leidos Biomedical Research, Inc.$811,365,654
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Bambra Strokes · Ppd Development Lp$526,656,217
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ContractsIn Vitro TestingMaintenanceAntifungal AgentsTherapeutic DevelopmentIn VitroAnti-Bacterial AgentsEfficacy TestingAnimal ModelStandardizationScreeningPathogenFungusAdvanced DevelopmentMouse ModelAntimicrobial ResistanceMycosesInfectious Disease ModelCommunicable DiseasesAnimal Model DevelopmentAspergillosisToxinCombatTranslational Research
Grant awards (65)
Task A29: In vitro screening for antifungal activity against fungal disease pathogens$78,390
N01 · FY2025 · AI · contact PI
Task A89: Candidate Testing in Murine Models of Fungal Infections$340,810
N01 · FY2024 · AI · contact PI
Task A26: In Vitro Screening for Antifungal Activity Against Fungal Disease Pathogens$69,565
N01 · FY2024 · AI · contact PI
Task A26: In Vitro Screening for Antifungal Activity Against Fungal Disease Pathogens$69,565
N01 · FY2024 · AI · contact PI
Task A65: Therapeutics Testing in Murine Models of Fungal Infections$39,367
N01 · FY2024 · AI · contact PI
TASK A22: IN VITRO SCREENING FOR ANTIFUNGAL ACTIVITY$100,462
N01 · FY2023 · AI · contact PI
TASK A20: IN VITRO SCREENING FOR ANTIFUNGAL ACTIVITY AGAINST FUNGAL DISEASE PATHOGENS$18,910
N01 · FY2023 · AI · contact PI
Task A65: Therapeutics testing in murine models of fungal infections$492,428
N01 · FY2022 · AI · contact PI
Task A65: Therapeutics testing in murine models of fungal infections$164,142
N01 · FY2022 · AI · contact PI
TASK A20: IN VITRO SCREENING FOR ANTIFUNGAL ACTIVITY AGAINST FUNGAL DISEASE PATHOGENS$66,048
N01 · FY2022 · AI · contact PI
Task A15: In vitro screening for antibacterial activity against public health disease pathogens$21,044
N01 · FY2022 · AI · contact PI
TASK A13: IN VITRO SCREENING FOR ANTIFUNGAL ACTIVITY AGAINST FUNGAL DISEASE PATHOGENS$14,317
N01 · FY2022 · AI · contact PI
TASK A13: IN VITRO SCREENING FOR ANTIFUNGAL ACTIVITY AGAINST FUNGAL DISEASE PATHOGENS$14,317
N01 · FY2022 · AI · contact PI
Task A34: Therapeutics testing in murine models of fungal infections$181,074
N01 · FY2021 · AI · contact PI
Task A34: Therapeutics testing in murine models of fungal infections$168,907
N01 · FY2021 · AI · contact PI
Task A15: In vitro screening for antibacterial activity against public health disease pathogens$105,220
N01 · FY2021 · AI · contact PI
TASK A13: IN VITRO SCREENING FOR ANTIFUNGAL ACTIVITY AGAINST FUNGAL DISEASE PATHOGENS$78,756
N01 · FY2021 · AI · contact PI
Task A09: In vitro screening for antibacterial activity against public health disease pathogens$99,320
N01 · FY2020 · AI · contact PI
TASK A04: In vitro screening for antifungal activity against fungal disease pathogens$44,252
N01 · FY2020 · AI · contact PI
Task A34: Therapeutics testing in murine models of fungal infections$568,877
N01 · FY2019 · AI · contact PI
Task A01: Efficacy Testing in Mouse Models of Fungal Infections$359,348
N01 · FY2019 · AI · contact PI
TASK A04: In vitro screening for antifungal activity against fungal disease pathogens$50,302
N01 · FY2019 · AI · contact PI
TASK A33: IN VITRO SCREENING FOR ANTIFUNGAL ACTIVITY$21,670
N01 · FY2019 · AI · contact PI
In Vitro Assessment for Antimicrobial Activity Support (Task Area A)$2,500
N01 · FY2019 · AI · contact PI
Task A01: Efficacy Testing in Mouse Models of Fungal Infections$486,450
N01 · FY2018 · AI · contact PI
Task A32: IN VITRO TESTING FOR ANTIMICROBIAL RESISTANT-RELATED ANTIBACTERIAL ACTIVITY$291,620
N01 · FY2018 · AI · contact PI
Task A36: In vitro testing for antimicrobial resistant-related antibacterial activity$218,715
N01 · FY2018 · AI · contact PI
TASK A33: IN VITRO SCREENING FOR ANTIFUNGAL ACTIVITY$77,895
N01 · FY2018 · AI · contact PI
Task A22: Development of a new system for scaled-up culture and propagation of Pneumocystis$59,638
N01 · FY2018 · AI · contact PI
TASK A28: In Vitro Screening for Antifungal Activity$20,885
N01 · FY2018 · AI · contact PI
Task A97: Gender differences in Invasive Aspergillosis (IA) murine models$14,920
N01 · FY2018 · AI · contact PI
Task A102:Mucormycosis Models$14,848
N01 · FY2018 · AI · contact PI
Task A08: ANIMAL MODELS OF INFECTIOUS DISEASES SUPPORT$2,342
N01 · FY2018 · AI · contact PI
TASK A29: In vitro testing for Antimicrobial Resistant-related antibacterial activity$218,716
N01 · FY2017 · AI · contact PI
Task A22: Development of a new system for scaled-up culture and propagation of Pneumocystis$74,331
N01 · FY2017 · AI · contact PI
TASK A107: MURINE MODEL EFFICACY TESTING - ASPERGILLOSIS AND CANDIDIASIS$71,353
N01 · FY2017 · AI · contact PI
TASK A28: In Vitro Screening for Antifungal Activity$48,978
N01 · FY2017 · AI · contact PI
TASK A28: In Vitro Screening for Antifungal Activity$5,442
N01 · FY2017 · AI · contact PI
Task A21: In vitro testing against fungal pathogens$4,456
N01 · FY2017 · AI · contact PI
Task A21: In vitro testing against fungal pathogens$1,486
N01 · FY2017 · AI · contact PI
Task A102:Mucormycosis Models$680,631
N01 · FY2016 · AI · contact PI
Task A97: Gender differences in Invasive Aspergillosis (IA) murine models$644,828
N01 · FY2016 · AI · contact PI
Task A93: Murine model Efficacy testing-Aspergillosis, Candidiasis and Mucormycosis$581,176
N01 · FY2016 · AI · contact PI
Task A93: Murine model Efficacy testing-Aspergillosis, Candidiasis and Mucormycosis$313,033
N01 · FY2016 · AI · contact PI
Task A93: Murine model Efficacy testing-Aspergillosis, Candidiasis and Mucormycosis$296,014
N01 · FY2016 · AI · contact PI
Task A98: Antifungal in vivo Efficacy Testing-Coccidioides$275,010
N01 · FY2016 · AI · contact PI
Task A26: In vitro testing for Antimicrobial Resistant-related antibacterial activity$208,965
N01 · FY2016 · AI · contact PI
Task A22:Culturing Pneumocystis jiroveci$154,847
N01 · FY2016 · AI · contact PI
Task A21: In vitro testing against fungal pathogens$80,010
N01 · FY2016 · AI · contact PI
Task A05:SMALL ANIMAL MODEL DEVELOPMENT AND UTILIZATION FOR ASPERGILLOSIS$29,922
N01 · FY2016 · AI · contact PI
Task A13 Small animal model development for invasive fungal disease$21,880
N01 · FY2016 · AI · contact PI
Task A17 - In Vitro Assessment for Antimicrobial Activity - Antifungals$5,406
N01 · FY2016 · AI · contact PI
Task A16: In Vitro Assessment for Antimicrobial Activity$204,867
N01 · FY2015 · AI · contact PI
Task A17 - In Vitro Assessment for Antimicrobial Activity - Antifungals$50,979
N01 · FY2015 · AI · contact PI
Task A17: In Vitro Assessment for Antimicrobial Activity - Antifungals$5,664
N01 · FY2015 · AI · contact PI
Task A12: In Vitro Screening for Antibacterial Activity$4,086
N01 · FY2015 · AI · contact PI
Task A50:STAPHYLOCOCCUS AUREUS SMALL ANIMAL MODEL PROOF-OF-CONCEPT TESTING$200,805
N01 · FY2014 · AI · contact PI
Task A12: In Vitro Screening for Antibacterial Activity$147,976
N02 · FY2014 · AI · contact PI
Task A10: In Vitro Antifungal Efficacy Testing$58,703
N02 · FY2014 · AI · contact PI
Task A10: In Vitro Antifungal Efficacy Testing$6,522
N02 · FY2014 · AI · contact PI
Task A13 Small animal model development for invasive fungal disease$2,393,023
N01 · FY2011 · AI · contact PI
Task A24: Staphylococcus Aureus Animal Models$651,717
N01 · FY2011 · AI · contact PI
Task A05: Small Animal Models for Fungal Diseases$328,740
N01 · FY2011 · AI · contact PI
In Vitro Assessments for Antimicrobial Activity$25,000
N01 · FY2011 · AI · contact PI
Invasive Aspergillosis Animal Models$800,000
N01 · FY2010 · AI · contact PI